Evidence map›Paper›PMID 31235485›Full record

ArticleBioscience reports2019

Investigation of

Jing Yang, Jiaochun Liu, Yu Chen, Weifeng Tang, Kai Bo, Yuling Sun, Jianping Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Impact ofCell cycle (Georgetown, Tex.) · 2023
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Jing YangDepartment of Gastroenterology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu Province, China.
Jiaochun LiuDepartment of Gastroenterology, People's Liberation Army 92nd Hospital, Nanping, Fujian Province,China.
Yu ChenCancer Bio-immunotherapy Center, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian Province, China.
Weifeng TangDepartment of Cardiothoracic Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu Province, China.ORCID 0000-0002-4157-4057
Kai BoDepartment of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Yuling SunDepartment of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China cjp7668@163.com ylsun@zzu.edu.cn.
Jianping ChenDepartment of Gastroenterology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu Province, China cjp7668@163.com ylsun@zzu.edu.cn.
Soochow University · CNFirst Affiliated Hospital of Zhengzhou University · CNFujian Medical University · CNJiangsu University · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single nucleotide polymorphisms (SNPs) in immune related gene may influence the susceptibility of cancer. We selected

Indexed as

AgedAllelesB7-1 AntigenCarcinoma, HepatocellularCD28 AntigensFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHepatitis B, ChronicHomozygoteHumansInducible T-Cell Co-Stimulator ProteinLiver NeoplasmsMaleMiddle AgedB7-1 AntigenCD28 AntigensCD80 protein, humanICOS protein, humanInducible T-Cell Co-Stimulator ProteinCD28CD80Hepatocellular carcinomaICOSPolymorphismRisk

Identifiers

PMID31235485
PMCPMC6609557
OpenAlexW2955352848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.